fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
Compounds & libraries eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our Blog

Review us on Google
Dear customers, ChemDiv appreciates your business and puts customer experience and satisfaction as our priority. Please take a moment to tell ...
Read More
WE CARE ABOUT YOUR OPINION
ChemDiv invites you to participate in our customer experience survey. Our team works hard to provide the best service for you. ...
Read More
CHEMDIV CARES ABOUT YOU
We greatly appreciate your business and put customer experience and satisfaction as our top priority. ...
Read More
Read Our Blog >

Pharma News

Eli Lilly’s Loxo Oncology Enters into $1.6 Billion Research and Collaboration Agreement with Merus N.V.
January 22, 2021
Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
January 22, 2021
Servier and MiNA Partner to Create Entirely New Class of Drugs
January 22, 2021
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X